Cargando…

Acquired Class D β-Lactamases

The Class D β-lactamases have emerged as a prominent resistance mechanism against β-lactam antibiotics that previously had efficacy against infections caused by pathogenic bacteria, especially by Acinetobacter baumannii and the Enterobacteriaceae. The phenotypic and structural characteristics of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, Nuno T., Fisher, Jed F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790369/
https://www.ncbi.nlm.nih.gov/pubmed/27025753
http://dx.doi.org/10.3390/antibiotics3030398
_version_ 1782420981477801984
author Antunes, Nuno T.
Fisher, Jed F.
author_facet Antunes, Nuno T.
Fisher, Jed F.
author_sort Antunes, Nuno T.
collection PubMed
description The Class D β-lactamases have emerged as a prominent resistance mechanism against β-lactam antibiotics that previously had efficacy against infections caused by pathogenic bacteria, especially by Acinetobacter baumannii and the Enterobacteriaceae. The phenotypic and structural characteristics of these enzymes correlate to activities that are classified either as a narrow spectrum, an extended spectrum, or a carbapenemase spectrum. We focus on Class D β-lactamases that are carried on plasmids and, thus, present particular clinical concern. Following a historical perspective, the susceptibility and kinetics patterns of the important plasmid-encoded Class D β-lactamases and the mechanisms for mobilization of the chromosomal Class D β-lactamases are discussed.
format Online
Article
Text
id pubmed-4790369
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-47903692016-03-24 Acquired Class D β-Lactamases Antunes, Nuno T. Fisher, Jed F. Antibiotics (Basel) Review The Class D β-lactamases have emerged as a prominent resistance mechanism against β-lactam antibiotics that previously had efficacy against infections caused by pathogenic bacteria, especially by Acinetobacter baumannii and the Enterobacteriaceae. The phenotypic and structural characteristics of these enzymes correlate to activities that are classified either as a narrow spectrum, an extended spectrum, or a carbapenemase spectrum. We focus on Class D β-lactamases that are carried on plasmids and, thus, present particular clinical concern. Following a historical perspective, the susceptibility and kinetics patterns of the important plasmid-encoded Class D β-lactamases and the mechanisms for mobilization of the chromosomal Class D β-lactamases are discussed. MDPI 2014-08-21 /pmc/articles/PMC4790369/ /pubmed/27025753 http://dx.doi.org/10.3390/antibiotics3030398 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Antunes, Nuno T.
Fisher, Jed F.
Acquired Class D β-Lactamases
title Acquired Class D β-Lactamases
title_full Acquired Class D β-Lactamases
title_fullStr Acquired Class D β-Lactamases
title_full_unstemmed Acquired Class D β-Lactamases
title_short Acquired Class D β-Lactamases
title_sort acquired class d β-lactamases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790369/
https://www.ncbi.nlm.nih.gov/pubmed/27025753
http://dx.doi.org/10.3390/antibiotics3030398
work_keys_str_mv AT antunesnunot acquiredclassdblactamases
AT fisherjedf acquiredclassdblactamases